LSX World Congress

STRATEGY, INVESTMENT, PARTNERING & COMMERCIALISATION FOR LIFE SCIENCE & HEALTHCARE EXECUTIVE LEADERS

 

8th Annual



Physical
8-9 February 2022
133 Houndsditch, Liverpool St London, UK

Virtual
14-25 February 2022


DOWNLOAD BROCHURE

What is LSX World Congress



For the last 7 years, the LSX World Congress has been bringing together the executives that matter to the future of healthcare and life science strategy, investment, partnering and deal making.

LSX World Congress gathers the founders and CEOs of innovative start-ups through to publicly healthcare giants, and everyone in between. It represents the breadth and depth of the cutting-edge research and technology driving the advances in the industry right now and in the near future.

The biotech, healthtech and medtech industry’s c-suite will be joined by the sector’s most active investors, pharma and health technology BD&L teams, R&D leaders, KOLs and top tier service companies who are driving the sector forward.

In an industry as dynamic as this, LSX World Congress brings together the people who are developing technologies, solutions and new business models to tackle the biggest healthcare challenges in the industry today, and helps answer the question; what’s next and how do we get there?

With our relentless focus on quality peer-to-peer discussion, high-level networking and partnering, intimate conference formats and a vetted, high-calibre audience, we help you Connect with Purpose.


3-Track Therapeutic & Technology Sector Focus


Biotech Leaders

Medtech Leaders

Healthtech Leaders

 

Helping Solve Your Most Urgent Priorities


Speakers on stage

INDUSTRY & MARKET INTELLIGENCE

Forum

STRATEGY & COMMERCIALISATION

Forum 2

INVESTMENT & CAPITAL RAISING

Partnering

PARTNERING & DEAL MAKING


Early Confirmed Speakers


Matthias Müllenbeck, SVP, Head Global BD & Alliance Management, Merck KGaA

Matthias Müllenbeck

SVP, Head Global BD & Alliance Management
Merck KGaA
Sander Slootweg, Managing Partner, Forbion

Sander Slootweg

Managing Partner
Forbion
Werner Lanthaler, CEO, Evotec

Werner Lanthaler

CEO
Evotec
Jacob Sten Petersen, Corporate VP, Head of Stem Cell R&D, Novo Nordisk

Jacob Sten Petersen

Corporate VP, Head of Stem Cell R&D
Novo Nordisk
Stephanie Sirota, Partner and CBO, RTW Investments

Stephanie Sirota

Partner and CBO
RTW Investments
Khatereh Ahmadi, Head of Search and Evaluation Team, European BD&L Hub, MSD

Khatereh Ahmadi

Head of Search and Evaluation Team, European BD&L Hub
MSD
Tim Luker, VP Venture Science, Corporate BD, Eli Lilly

Tim Luker

VP Venture Science, Corporate BD
Eli Lilly
Guillaume Vignon, SVP BD, Beigene

Guillaume Vignon

SVP BD
Beigene
David Germonpre, Partner, MTIP AG

David Germonpre

Partner
MTIP AG
Mark Davies, Chief Medical Officer, IBM

Mark Davies

Chief Medical Officer
IBM
Caoimhe Vallely-Gilroy, Global Head of Digital Health & Therapeutics, Merck

Caoimhe Vallely-Gilroy

Global Head of Digital Health & Therapeutics
Merck
Chris Robson, CEO, Living With

Chris Robson

CEO
Living With
Wilfred Van Zuilen, President EMEA, Zimmer Biomet

Wilfred Van Zuilen

President EMEA
Zimmer Biomet
Charity Kufaas, VP BD and Strategy, Medtronic

Charity Kufaas

VP BD and Strategy
Medtronic
Xavier Bertrand, VP Healthcare Services and Alliances, Boston Scientific

Xavier Bertrand

VP Healthcare Services and Alliances
Boston Scientific
Antonio Sanchez-Cordero, VP Business Development (M&A) Peripheral Intervention, BD

Antonio Sanchez-Cordero

VP Business Development (M&A) Peripheral Intervention
BD

SEE ALL SPEAKERS

2022 Key Event Stats


2500+

REGISTERED PARTICIPANTS

500+

INVESTORS, STRATEGICS & PHARMA

1500+

UNIQUE ORGANISATIONS

500+

BIOTECH, MEDTECH, HEALTHTECH

& DEEPTECH COMPANIES

100+

COMPANY

SHOWCASES

1:1 BOOTHS

PRIVATE ROOMS FOR BUSINESS 1:1 MEETINGS

Platinum Partners


Eli Lilly
Nasdaq
ZS

Knowledge Partner


McKinsey

Gold Partners


Beigene
Bird & Bird 300x150

Cello BioConsulting
Cello Health Consulting 300x150
citi 300x150

DLA Piper
EY
Goodwin 300x150

Potter Clarkson
Latham & Watkins 300x
Medtronic 300x150
MSD Inventing For Life
Mintz
NDA Group
Novo Nordisk
Innovate UK
Premier Research 300x150
SVB Leerink 300x150

Pharma Digital Leaders Partner


Deloitte

Chinese Investor Partner


MAVIE Technologies

Silver Partners


Clifford Chance
Fish & Richardson
Greenlight Guru
Halloran 300x
Huron 300x
IMMR

Lonza

Merck

Sagentia Innovation

DOWNLOAD BROCHURE
Female Founders

Networking, Dialogue And Mentorship For Women In Health And Life Sciences
Members save 25% off all LSX events.

FIND OUT MORE

Subscribe to hear speaker announcements, ticket offers and more